MD Anderson Research Highlights for November 16, 2022
November 17, 2022
November 17, 2022
HOUSTON, Texas, Nov. 17 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring a new combination therapy for advanced AML, a link between the microbiome and treatment-related fever, and a therapeutic target for immunotherapy-related colitis
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and cli . . .
* * *
Featuring a new combination therapy for advanced AML, a link between the microbiome and treatment-related fever, and a therapeutic target for immunotherapy-related colitis
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and cli . . .